Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma Emmanouil Sinakos,

Slides:

Advertisements

Similar presentations

Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.

Advertisements

The Role of Psychosocial Care in Adapting to Health Care Reform

Abnormal Liver Tests and Fatty Liver on Ultrasound

Thrombocytopenia With Abnormal Liver Function Tests

Classification, Diagnosis, and Management of Cholangiocarcinoma

Saurabh Dawra, Vishal Sharma, Usha Dutta

Flavia D. Mendes, Ayako Suzuki, Schuyler O. Sanderson, Keith D

Noncardiac Chest Pain Clinical Gastroenterology and Hepatology

Pichamol Jirapinyo, Christopher C. Thompson

Shou–Jiang Tang, Feriyl Bhaijee

Katsunori Matsueda, Tatsuya Toyokawa

A Shocking Cystory Clinical Gastroenterology and Hepatology

Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient Severin Daum, Christoph Loddenkemper,

Right Upper Quadrant Pain and a Normal Abdominal Ultrasound

Amy E. Schindler, Jonathan A. Schneider, Keith L. Obstein

Retroperitoneal Benign Schwannoma in the Suprapancreatic Area

Judy A. Trieu, Mohammad Bilal, Ali Hashmi

Ampullary Carcinoid: Diagnostic Challenges and Update on Management

Granular Cell Tumor in Colonic Polyp Found on Screening Colonoscopy

Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia Gene K. Ma, Uri Ladabaum Clinical Gastroenterology.

Issue Highlights Clinical Gastroenterology and Hepatology

Atopic Characteristics of Adult Patients With Eosinophilic Esophagitis

Activity-Based Costing and Management in a Hospital-Based GI Unit

Amie L. Harvey, Tommy Yen, Anand Kunda

When Should Screening Stop for Elderly Individuals at Average and Increased Risk for Colorectal Cancer? Folasade P. May, Samir Gupta Clinical Gastroenterology.

Rohan M. Modi, Christina A. Arnold, Peter P. Stanich

Joanna Gibson, Jill Lacy, Ellen Matloff, Marie Robert

Low Serum Vitamin D During Remission Increases Risk of Clinical Relapse in Patients With Ulcerative Colitis John Gubatan, Shuji Mitsuhashi, Talia Zenlea,

Abnormal Liver Tests and Fatty Liver on Ultrasound

New Models of Gastroenterology Practice

Ramesh Kumar, Masiullah, Pintu Kumar Singh

Dushyant Singh, Reetu Singh, Wendell K. Clarkston

Colon Neoplasms Develop Early in the Course of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis Erin W. Thackeray, Phunchai Charatcharoenwitthaya,

An Asymptomatic, Radiographically Undetected Hepatocellular Carcinoma That Presented as a Large Retropancreatic Mass Najat Mourra, Lionel Arrive, François.

Cholelithiasis in a Patient With History of Cholecystectomy

Kamal V. Patel, Rishi M. Goel, Terry Wong

Patient-Reported Outcomes of Cirrhosis

Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease Aoibhlinn O'Toole, Alaa Alakkari, Denise Keegan, Glen Doherty, Hugh.

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Utility of Pulse Oximetry Screening for Hepatopulmonary Syndrome

Mohamad H. Imam, Marina G. Silveira, Emmanouil Sinakos, Andrea A

Elizabeth Mileti, Philip Rosenthal, Marion G. Peters

Volume 151, Issue 4, Pages (October 2016)

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Hepatic Cyst? Clinical Gastroenterology and Hepatology

Thrombocytopenia With Abnormal Liver Function Tests

Walter Reinisch, Jean-Frederic Colombel, William J

Meenakshi Bewtra, Chinyu Su, James D. Lewis

Patrícia Andrade, Susana Lopes, Guilherme Macedo

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Abdominal Aortitis Associated With Autoimmune Pancreatitis

Minimal-Change Esophagitis on Narrow-Band Imaging

A 42–Year–Old Woman With a New Diagnosis of Sclerosing Cholangitis

Failure to Renew Prescriptions for Gastroprotective Agents to Patients on Continuous Nonsteroidal Anti-inflammatory Drugs Increases Rate of Upper Gastrointestinal.

Eric M. Nelsen, Darya Buehler, Patrick R. Pfau

Coagulation in Liver Disease: A Guide for the Clinician

Issue Highlights Clinical Gastroenterology and Hepatology

Chun-Hua Zhou, Wei-Xia Zhou, Duan-Min Hu

Diagnosis of Primary Splenic Flexure Schwannoma Before Surgery Based on Endoscopic-Ultrasound–Guided Fine-Needle Biopsy Guru Trikudanathan, Sophia Smith,

Coloduodenal Fistula in Crohn’s Disease

Utility of Pulse Oximetry Screening for Hepatopulmonary Syndrome

Rintaro Hashimoto, Akimichi Chonan

Adverse Outcomes: Why Bad Things Happen to Good People

Ajaypal Singh, John D. Christein, Shyam Varadarajulu

M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu

Rintaro Hashimoto, Akimichi Chonan

The Role of Psychosocial Care in Adapting to Health Care Reform

Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction

Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis Knut Stokkeland, Jonas Höijer, Matteo Bottai, Karin Söderberg-Löfdal,

Choosing Wisely and the Perceived Drivers of Endoscopy Use

Presentation transcript:

Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma Emmanouil Sinakos, Amy K. Saenger, Jill Keach, W. Ray Kim, Keith D. Lindor Clinical Gastroenterology and Hepatology Volume 9, Issue 5, Pages 434-439.e1 (May 2011) DOI: 10.1016/j.cgh.2011.02.007 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Selection of patients for study inclusion. Clinical Gastroenterology and Hepatology 2011 9, 434-439.e1DOI: (10.1016/j.cgh.2011.02.007) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 Median CA 19-9 values per CCA diagnosis. The T bars represent the interquartile range of the values. Clinical Gastroenterology and Hepatology 2011 9, 434-439.e1DOI: (10.1016/j.cgh.2011.02.007) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 ROC curve for CA 19-9. AUC for detecting the presence of CCA is 0.77. Clinical Gastroenterology and Hepatology 2011 9, 434-439.e1DOI: (10.1016/j.cgh.2011.02.007) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 Factors known to affect the concentrations of CA 19-9 in patients without CCA. Clinical Gastroenterology and Hepatology 2011 9, 434-439.e1DOI: (10.1016/j.cgh.2011.02.007) Copyright © 2011 AGA Institute Terms and Conditions